MA-10 cells transfected with the human lutropin/choriogonadotropin receptor (hLHR): A novel experimental paradigm to study the functional properties of the hLHR

Endocrinology

Volumn 143, Issue 3, 2002, Pages 1026-1035

  Hirakawa, Takashi ^a   Galet, Colette ^a   Ascoli, Mario ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN RECEPTOR; CYCLIC AMP; INOSITOL PHOSPHATE; LUTEINIZING HORMONE; LUTEINIZING HORMONE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROGESTERONE; RECOMBINANT RECEPTOR; STEROID;

ADENOMA; ANIMAL CELL; ARTICLE; CELL HYPERPLASIA; CELL STRAIN; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LEYDIG CELL TUMOR; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DENSITY; STEROIDOGENESIS;

EID: 0036171565     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.143.3.8702     Document Type: Article

References (58)

1. The lutropin/choriogonadotropin (LH/CG) receptor...4 years later
2. The lutropin/choriogonadotropin receptor. A 2002 perspective
3. Signaling networks: The origins of cellular multitasking
4. Emergent properties of networks of biological signaling pathways
5. New signaling pathways for hormones and cAMP in endocrine cells
6. Characterization of several clonal lines of cultured Leydig tumor cells: Gonadotropin receptors and steroidogenic responses
7. Immortalized Leydig cell lines as models for studying Leydig cell physiology
8. Effect of activating and inactivating mutations on the phosphorylation and trafficking of the human lutropin/choriogonadotropin receptor
9. High-efficiency transformation of mammalian cells by plasmid DNA
10. Removal of surface-bound human choriogonadotropin results in cessation of hormonal responses in cultured Leydig tumor cells
11. Inhibition of choriogonadotropin-activated steroidogenesis in cultured Leydig tumor cells by the Rp diastereoisomer of adenosine 3′,5′-cyclic phosphorothioate
12. Mutation of a highly conserved acidic residue present in the second intracellular loop of G protein-coupled receptors does not impair hormone binding or signal transduction of the LH/CG receptor
13. The inositol phosphate/diacyl-glycerol pathway in MA-10 Leydig tumor cells. Activation by arginine vasopressin and lack of effect of epidermal growth factor and human choriogonadotropin
14. Identification and characterization of a luteinizing hormone/chorionic gonadotropin (LH/CG) receptor precursor in a human kidney cell line stably transfected with the rat luteal LH/CG receptor complementary DNA
15. A polyclonal antibody to a synthetic peptide derived from the rat FSH receptor reveals the recombinant receptor as a 74 kDa protein
16. p38JAB1 binds to the intracellular precursor of the lutropin/choriogonadotropin receptor and promotes its degradation
17. Gonadotropin binding and stimulation of steroidogenesis in Leydig tumor cells
18. Role of the rate of internalization of the agonist-receptor complex on the agonist-induced down-regulation of the lutropin/choriogonadotropin receptor
19. Temperature sensitivity of some mutants of the lutropin/choriogonadotropin receptor
20. Seven non-contiguous intracellular residues of the lutropin/choriogonadotropin receptor dictate the rate of agonist-induced internalization and its sensitivity to non-visual arrestins
21. Mutations of the second extracellular loop of the human lutropin receptor emphasize the importance of receptor activation and de-emphasize the importance of receptor phosphorylation in agonist-induced internalization
22. Identification of two distinct structural motifs that, when added to the C-terminal tail of the rat lutropin receptor, redirect the internalized hormone-receptor complex from a degradation to a recycling pathway
23. Novel molecular mediators in the pathway connecting G protein-coupled receptors to MAP kinase cascades
24. G-protein-coupled receptors and signaling networks: Emerging paradigms
25. G protein-coupled receptors. II. Mechanisms of agonist activation
26. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors
27. Attenuation of cAMP-mediated responses in MA-10 Leydig tumor cells by genetic manipulation of a cAMP-phosphodiesterase
28. Gonadotropin binding and stimulation of cyclic adenosine 3′:5′-monosphosphate and testosterone production in isolated Leydig cells
29. Mutations of gonadotropins and gonadotropin receptors: Elucidating the physiology and pathophysiology of pituitary-gonadal function
30. Naturally occurring mutations of the luteinizing-hormone receptor: Lessons learned about reproductive physiology and G protein-coupled receptors
31. Genetic heterogeneity of constitutively activating mutations of the human luteinizing hormone receptor in familial male-limited precoious puberty
32. A case of male-limited precocious puberty caused by a point mutation in the second transmembrane domain of the luteinizing hormone choriogonadotropin receptor gene
33. Severe testotoxicosis phenotype associated with Asp578->Tyr mutation of the lutrophin/choriogonadotrophin receptor gene
34. A unique constitutively activating mutation in third transmembrane helix of luteinizing hormone receptor causes sporadic male gonadotropin-independent precocious puberty
35. Leydig-cell tumors caused by an activating mutation of the gene encoding the luteinizing hormone receptor
36. Pleiotropic effects of substitutions of a highly conserved leucine in transmembrane helix III of the human lutropin/choriogonadotropin receptor with respect to constitutive activation and hormone responsiveness
37. Lutropin/choriogonadotropin down-regulates its receptor by both receptor mediated endocytosis and a cAMP-dependent reduction in receptor mRNA
38. Epidermal growth factor, a phorbol ester and cAMP decrease the transcription of the LH/CG receptor gene in MA-10 Leydig tumor cells
39. p-Nonyl-phenol: An estrogenic xenobiotic released from "modified" polystyrene
40. Bisphenol-A: An estrogenic substance is released from plycarbonate flasks during autoclaving
41. Diversity and selectivity of receptor-G protein interaction
42. G protein-coupled receptors. III. New roles for receptor kinases and β-arrestins in receptor signaling and desensitization
43. Heptahelical receptor signaling: Beyond the G protein paradigm
44. Regulation of tyrosine kinase cascades by G-protein-coupled receptors
45. Regulation of signal transduction by endocytosis
46. Growth factor receptor signalling: Location, location, location
47. β-Arrestin 2: A receptor-regulated MAPK scaffold for the actiation of JNK3
48. 2+ mobilization
49. The luteinizing hormone receptor activates phospholipase C via preferential coupling to Gi2
50. Human chorionic gonadotropin- and phorbol ester stimulated phosphorylation of the LH/CG receptor maps to serines 635, 639, 645 and 652 in the C-terminal cytoplasmic tail
51. Phosphorylation of the lutropin/choriogonadotropin receptor facilitates uncoupling of the receptor from adenylyl cyclase and endocytosis of the bound hormone
52. 578 in maintaining the inactive conformation of the human lutropin/choriogonadotropin receptor
53. The C-terminal third of the human luteinizing hormone (LH) receptor is important for inositol phosphate release: Analysis using chimeric human LH/follicle-stimulating hormone receptors
54. An anionic residue at position 564 is important for maintaining the inactive conformation of the human lutropin/choriogonadotropin receptor
55. Protein kinase C activity can desensitize the gonadotropin-responsive adenylate cyclase in Leydig tumor cells
56. Involvement of Gs and Gi proteins in dual coupling of the luteinizing hormone receptor to adenylyl cyclase and phospholipase C
57. Normal prenatal but arrested postnatal sexual development of luteinizing hormone receptor knockout (LuRKO) mice
58. Targeted disruption of luteinizing hormone/human chorionic gonadotropin receptor gene